Placebo-Controlled Double-Blind Dose-Response Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia (Including Gout
JOURNAL OF CLINICAL RHEUMATOLOGY ; 20 , 6 ; E2
2014-01-01
E2
Aufsatz (Zeitschrift)
Englisch
DDC: | 616.723 |
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
British Library Online Contents | 2014
British Library Online Contents | 2015
|